Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009-Reference-Cited by-同舟云学术

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009

Published:2010-08 Issue:8 Volume:21 Page:1579-1584
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Adam R.,Haller D.G.,Poston G.,Raoul J.-L.,Spano J.-P.,Tabernero J.,Van Cutsem E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/8/1579/361064/mdq043.pdf

Reference54 articles.

1. Global Cancer Facts and Figures 2007;Garcia,2007

2. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

4. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

5. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;Giantonio;J Clin Oncol,2007

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local-Regional Therapy for Oligometastatic Colorectal Cancer;The Cancer Journal;2024-07

2. Novel targeting formulations in colorectal cancer;Colorectal Cancer;2024

3. Multiple colorectal liver metastases resection can offer long-term survival: The concept of a chronic neoplastic disease;Surgery;2023-04

4. AKR1B10 accelerates the production of proinflammatory cytokines via the NF-κB signaling pathway in colon cancer;Journal of Molecular Histology;2022-08-03

5. Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study;BMC Cancer;2022-07-21